Having created the BRIC acronym to capture the collective potential of Brazil, Russia, India, and China to influence the world economy, I now must ask a rather awkward question: When is that influence going to show up?
Just two years ago, the topic of drug-resistant infections would usually be met with questions like "What is AMR?" or, "Why would a finance minister take charge of a health crisis?" Few understood the scale and multifaceted nature of the challenge, and thus the need for a comprehensive approach.
Having created the BRIC acronym to capture the collective potential of Brazil, Russia, India, and China to influence the world economy, I now must ask a rather awkward question: When is that influence going to show up?
Just two years ago, the topic of drug-resistant infections would usually be met with questions like "What is AMR?" or, "Why would a finance minister take charge of a health crisis?" Few understood the scale and multifaceted nature of the challenge, and thus the need for a comprehensive approach.
